Skip to main content
Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)

Research Question:
Does convalescent plasma help treat participants who are COVID-19 positive?

Basic Study Information

Purpose:
The purpose of this study is to is to determine if convalescent plasma will help a person with COVID-19 symptoms improve and prevent admission into the hospital. Convalescent plasma is plasma from a person who has recovered from a COVID-19 infection. Participants in this study will receive either control or convalescent plasma. COVID-19 symptoms include but are not limited to fever, cough, or loss of taste or smell. You must be 18 years or older to participate.

Location: Clinical Research Center
Study Reference #: 4965

Lead Researcher (Principal Investigator)

Lead Researcher:  Martin Zand

Study Contact Information

Study Coordinator: Susanne Heininger
Phone: (585) 273-1926
Email: Susanne_Heininger@URMC.Rochester.edu

Additional Study Details

Number of Visits:  2 to 5
Parking:  Free
Transportation Coverage:  No
Reimbursement:  Yes

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search